Lancet Haematol

Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study.

Schjesvold FH, Dimopoulos MA, Delimpasi S, ..., Sonneveld P, OCEAN (OP-103) Investigators

Lancet Haematol - (-) - [2022-01-12; online 2022-01-12]

Category: Drug Discovery Category: Health Type: Journal article

Sustained prothrombotic changes in convalescent patients with COVID-19.

von Meijenfeldt FA, Thålin C, Lisman T

Lancet Haematol 8 (7) e475 [2021-07-00; online 2021-06-26]

Type: Other

Coagulation disorder in COVID-19.

Kander T

Lancet Haematol 7 (9) e630-e632 [2020-09-00; online 2020-07-10]

Type: Other